18 September 2023

CEO Of Avance Clinical Nominated For Executive Of The Year In 2023 Citeline Pharma Intelligence Awards Japan

CEO Of Avance Clinical Nominated For Executive Of The Year In 2023 Citeline Pharma Intelligence Awards Japan

Adelaide, Australia | North Carolina, USA

vance Clinical, the award-winning Australian and North American market-leading CRO for biotechs, is proud to announce that Chief Executive Officer Yvonne Lungershausen has been nominated for Executive of the Year in the 2023 Citeline Pharma Intelligence Awards in Japan.

The Citeline Pharma Intelligence Award will be announced on October 17, 2023 in Tokyo. According to Citeline, the award, “is designed to acknowledge excellence in leadership, career achievements, influence within the industry and the key characteristics that make a good leader, such as decisive and clear strategy, team building and employee welfare.”

Avance Clinical has achieved outstanding success guided by Yvonne’s leadership, global vision and passion for quality and customer service. The company’s staff numbers have grown significantly by approximately 85% since Avance was established in 2019. In the last 12 months, Avance Clinical expanded its operations into the US, opened a North Carolina office and a new biometrics hub in Bangalore, India.

With her experience of over three decades in the Australian, New Zealand and US clinical trials drug development environment Yvonne has not only put Avance Clinical on the global map but hired and retained some of the best talents from across the globe.

Yvonne has helped champion a culture of innovation and adaptability within the company -successfully embracing emerging technologies and capitalizing on new market opportunities, hence strengthening its competitive position. Yvonne’s exceptional leadership has not only driven the company’s growth but has also positively impacted the lives of Avance Clinical’s employees, shareholders, and biotech clients.

She is highly regarded within the industry and is renowned for her exceptional expertise in addressing complex clinical trial challenges. She sees the importance of preparing for change fostering an adaptive and forward-thinking mindset within the organization. Her leadership is defined by a deep commitment to cultivating relationships and driving positive industry change.

CEO Yvonne Lungershausen said, “I am honored to be nominated for this award. It reflects not only my accomplishments as leader of the organization but our entire team’s efforts at Avance Clinical globally. Our team’s dedication and commitment to quality clinical research is what makes us so successful. We take pride in servicing the needs of our biotech clients and providing them with the very best, customized solutions.

“I am looking forward to attending the Citeline Pharma Intelligence awards ceremony in Tokyo in October – there is also the added benefit of being able to meet with and connect with our regional biotech clients,” she said.

 

About Avance Clinical

Avance Clinical is a full-service CRO for biotechs with a proven track-record for delivering clinical excellence in Australia, New Zealand, and North America. As the largest premium full-service CRO in Australia and North America, Avance Clinical specializes in delivering top-tier clinical trials that yield globally accepted data.

Award-winning CRO for Biotechs

Avance Clinical has been recognized for the fourth consecutive year by Frost & Sullivan in 2023, being awarded the Best Practices Customer Value Leadership for Biotech’s award, for its continuous exceptional performance.

Pre-clinical through to Phase I and Beyond

Avance Clinical offers pre-clinical consultancy services with their experienced ClinicReady team right through to Phase I and beyond clinical services leveraging significant Government incentive rebates of up to 43.5% and rapid start-up regulatory processes that are available in Australia. With experience across more than 110 therapeutic indications, Avance Clinical can deliver world-class, high-quality, internationally accepted data suitable for FDA and EMA review.

Technology

Avance Clinical uses state-of-the-art technology and gold-standard systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, Zelta, Veeva and Medrio are just some of Avance Clinical’s technology partners.

Related Articles